Literature DB >> 19060923

Cancer cells suppress p53 in adjacent fibroblasts.

J Bar1, R Feniger-Barish, N Lukashchuk, H Shaham, N Moskovits, N Goldfinger, D Simansky, M Perlman, M Papa, A Yosepovich, G Rechavi, V Rotter, M Oren.   

Abstract

The p53 tumor suppressor serves as a crucial barrier against cancer development. In tumor cells and their progenitors, p53 suppresses cancer in a cell-autonomous manner. However, p53 also possesses non-cell-autonomous activities. For example, p53 of stromal fibroblasts can modulate the spectrum of proteins secreted by these cells, rendering their microenvironment less supportive of the survival and spread of adjacent tumor cells. We now report that epithelial tumor cells can suppress p53 induction in neighboring fibroblasts, an effect reproducible by tumor cell-conditioned medium. The ability to suppress fibroblast p53 activation is acquired by epithelial cells in the course of neoplastic transformation. Specifically, stable transduction of immortalized epithelial cells by mutant H-Ras and p53-specific short inhibitory RNA endows them with the ability to quench fibroblast p53 induction. Importantly, human cancer-associated fibroblasts are more susceptible to this suppression than normal fibroblasts. These findings underscore a mechanism whereby epithelial cancer cells may overcome the non-cell-autonomous tumor suppressor function of p53 in stromal fibroblasts.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19060923      PMCID: PMC2727601          DOI: 10.1038/onc.2008.445

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  21 in total

1.  PTGF-beta, a type beta transforming growth factor (TGF-beta) superfamily member, is a p53 target gene that inhibits tumor cell growth via TGF-beta signaling pathway.

Authors:  M Tan; Y Wang; K Guan; Y Sun
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

Review 2.  Tumors are unique organs defined by abnormal signaling and context.

Authors:  D Radisky; C Hagios; M J Bissell
Journal:  Semin Cancer Biol       Date:  2001-04       Impact factor: 15.707

Review 3.  Fibroblasts in cancer.

Authors:  Raghu Kalluri; Michael Zeisberg
Journal:  Nat Rev Cancer       Date:  2006-05       Impact factor: 60.716

Review 4.  p53 in health and disease.

Authors:  Karen H Vousden; David P Lane
Journal:  Nat Rev Mol Cell Biol       Date:  2007-04       Impact factor: 94.444

5.  p53 Attenuates cancer cell migration and invasion through repression of SDF-1/CXCL12 expression in stromal fibroblasts.

Authors:  Neta Moskovits; Alexander Kalinkovich; Jair Bar; Tsvee Lapidot; Moshe Oren
Journal:  Cancer Res       Date:  2006-11-15       Impact factor: 12.701

6.  Evidence for nonautonomous effect of p53 tumor suppressor in carcinogenesis.

Authors:  Hippokratis Kiaris; Ioulia Chatzistamou; George Trimis; Matrisa Frangou-Plemmenou; Agatha Pafiti-Kondi; Anastasios Kalofoutis
Journal:  Cancer Res       Date:  2005-03-01       Impact factor: 12.701

7.  Breast-cancer stromal cells with TP53 mutations and nodal metastases.

Authors:  Attila Patocs; Li Zhang; Yaomin Xu; Frank Weber; Trinidad Caldes; George L Mutter; Petra Platzer; Charis Eng
Journal:  N Engl J Med       Date:  2007-12-20       Impact factor: 91.245

8.  Mesenchymal stem cells within tumour stroma promote breast cancer metastasis.

Authors:  Antoine E Karnoub; Ajeeta B Dash; Annie P Vo; Andrew Sullivan; Mary W Brooks; George W Bell; Andrea L Richardson; Kornelia Polyak; Ross Tubo; Robert A Weinberg
Journal:  Nature       Date:  2007-10-04       Impact factor: 49.962

9.  Stress-induced secretion of growth inhibitors: a novel tumor suppressor function of p53.

Authors:  E A Komarova; L Diatchenko; O W Rokhlin; J E Hill; Z J Wang; V I Krivokrysenko; E Feinstein; A V Gudkov
Journal:  Oncogene       Date:  1998-09-03       Impact factor: 9.867

10.  Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium.

Authors:  A F Olumi; G D Grossfeld; S W Hayward; P R Carroll; T D Tlsty; G R Cunha
Journal:  Cancer Res       Date:  1999-10-01       Impact factor: 12.701

View more
  33 in total

Review 1.  The p53 pathway as a target in cancer therapeutics: obstacles and promise.

Authors:  Anna Mandinova; Sam W Lee
Journal:  Sci Transl Med       Date:  2011-01-05       Impact factor: 17.956

2.  The cytokine IL-6 reactivates breast stromal fibroblasts through transcription factor STAT3-dependent up-regulation of the RNA-binding protein AUF1.

Authors:  Siti-Fauziah Hendrayani; Huda H Al-Khalaf; Abdelilah Aboussekhra
Journal:  J Biol Chem       Date:  2014-09-17       Impact factor: 5.157

3.  p21/waf1 and smooth-muscle actin α expression in stromal fibroblasts of oral cancers.

Authors:  Ioulia Chatzistamou; Nikolina Dioufa; George Trimis; Alexandra Sklavounou; Christos Kittas; Hippokratis Kiaris; Athanasios G Papavassiliou
Journal:  Cell Oncol (Dordr)       Date:  2011-05-11       Impact factor: 6.730

Review 4.  Cancer-associated fibroblasts and their putative role in potentiating the initiation and development of epithelial ovarian cancer.

Authors:  Isaiah G Schauer; Anil K Sood; Samuel Mok; Jinsong Liu
Journal:  Neoplasia       Date:  2011-05       Impact factor: 5.715

5.  p53 status in stromal fibroblasts modulates tumor growth in an SDF1-dependent manner.

Authors:  Yoseph Addadi; Neta Moskovits; Dorit Granot; Guillermina Lozano; Yaron Carmi; Ron N Apte; Michal Neeman; Moshe Oren
Journal:  Cancer Res       Date:  2010-10-15       Impact factor: 12.701

6.  Selection of p53-Deficient Stromal Cells in the Tumor Microenvironment.

Authors:  Elena Farmaki; Ioulia Chatzistamou; Panagiotis Bourlis; Eleni Santoukou; George Trimis; Athanasios G Papavassiliou; Hippokratis Kiaris
Journal:  Genes Cancer       Date:  2012-09

7.  Interleukin-1β promotes ovarian tumorigenesis through a p53/NF-κB-mediated inflammatory response in stromal fibroblasts.

Authors:  Isaiah Gregory Schauer; Jing Zhang; Zhen Xing; Xiaoqing Guo; Imelda Mercado-Uribe; Anil K Sood; Peng Huang; Jinsong Liu
Journal:  Neoplasia       Date:  2013-04       Impact factor: 5.715

Review 8.  Caught in the cross fire: p53 in inflammation.

Authors:  Tomer Cooks; Curtis C Harris; Moshe Oren
Journal:  Carcinogenesis       Date:  2014-06-18       Impact factor: 4.944

Review 9.  Involvement of stromal p53 in tumor-stroma interactions.

Authors:  Jair Bar; Neta Moskovits; Moshe Oren
Journal:  Semin Cell Dev Biol       Date:  2009-11-13       Impact factor: 7.727

10.  Altered p53 functionality in cancer-associated fibroblasts contributes to their cancer-supporting features.

Authors:  Sharathchandra Arandkar; Noa Furth; Yair Elisha; Nishanth Belugali Nataraj; Heiko van der Kuip; Yosef Yarden; Walter Aulitzky; Igor Ulitsky; Benjamin Geiger; Moshe Oren
Journal:  Proc Natl Acad Sci U S A       Date:  2018-06-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.